BETHKIS (Chiesi USA, Inc.)
Welcome to the PulseAid listing for the BETHKIS drug offered from Chiesi USA, Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Chiesi USA, Inc. |
NON-PROPRIETARY NAME: | tobramycin |
SUBSTANCE NAME: | TOBRAMYCIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-04-15 |
END MARKETING DATE: | 0000-00-00 |
BETHKIS HUMAN PRESCRIPTION DRUG Details:
Item Description | BETHKIS from Chiesi USA, Inc. |
LABELER NAME: | Chiesi USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/4mL) |
START MARKETING DATE: | 2013-04-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10122-820_76030f93-09fc-43b6-b86c-6f710bc9c922 |
PRODUCT NDC: | 10122-820 |
APPLICATION NUMBER: | NDA201820 |
Other TOBRAMYCIN Pharmaceutical Manufacturers / Labelers: